Report Detail
Global Budesonide and Formoterol Fumarate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4702037 |
- 01 June, 2026 |
- Global |
- 94 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Budesonide and Formoterol Fumarate market size was valued at US$ 2572 million in 2025 and is forecast to a readjusted size of US$ 4086 million by 2032 with a CAGR of 6.6% during review period.
Budesonide and Formoterol Fumarate is a compound inhalation preparation consisting of budesonide, an inhaled corticosteroid, and formoterol, a long-acting β₂-adrenergic agonist. It exerts both anti-inflammatory and bronchodilator effects: budesonide reduces airway inflammation and hyperresponsiveness, while formoterol relaxes bronchial smooth muscle rapidly. It is mainly used for the long-term management and maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), effectively relieving wheezing and dyspnea, and reducing the risk of acute exacerbations.In 2025, global Budesonide and Formoterol Fumarate production reached approximately 320 million units
Budesonide and formoterol is a core fixed-dose combination inhaled therapy for the global management of asthma and chronic obstructive pulmonary disease (COPD). With its dual mechanism of anti-inflammatory action and bronchodilation, it has long maintained a first-line clinical position. Historically dominated by originator brands, the global market has gradually diversified as patents expired and generic versions entered the market. Domestic and international generics have rapidly gained penetration through cost-effective advantages, driving higher overall market accessibility. On the demand side, rising global prevalence of chronic respiratory diseases, improved standardization of diagnosis and treatment, the implementation of tiered healthcare and chronic disease management policies, as well as consistent guideline recommendations for this combination therapy, collectively support steady market growth. At the same time, the sector faces challenges including intensified generic competition, pricing pressure, and patient share diversion from novel triple combinations and biological therapies. Overall, thanks to its well-established efficacy and broad indications, the product will continue to see stable market demand, with competition increasingly focusing on product quality, inhaler device optimization, cost control, and expansion in primary care and overseas markets.
This report is a detailed and comprehensive analysis for global Budesonide and Formoterol Fumarate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Budesonide and Formoterol Fumarate market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Budesonide and Formoterol Fumarate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Budesonide and Formoterol Fumarate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Budesonide and Formoterol Fumarate market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Budesonide and Formoterol Fumarate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Budesonide and Formoterol Fumarate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Viatris, Teva, Sandoz, Chia Tai Tianqing Pharmaceutical, Joincare Pharmaceutical Group Industry, Lunan Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Budesonide and Formoterol Fumarate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
80/4.5 μg / inhalation
160/4.5 μg / inhalation
Market segment by Dosage Form
Inhalation Powder
Inhalation Aerosol
Market segment by Production Technology
Innovator
Generic
Market segment by Sales Channels
Hospitals
Retail
Online
Market segment by Application
Asthma
Chronic Obstructive Pulmonary Disease
Airway Constriction Relief
Others
Major players covered
AstraZeneca
Viatris
Teva
Sandoz
Chia Tai Tianqing Pharmaceutical
Joincare Pharmaceutical Group Industry
Lunan Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Budesonide and Formoterol Fumarate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Budesonide and Formoterol Fumarate, with price, sales quantity, revenue, and global market share of Budesonide and Formoterol Fumarate from 2021 to 2026.
Chapter 3, the Budesonide and Formoterol Fumarate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Budesonide and Formoterol Fumarate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Budesonide and Formoterol Fumarate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Budesonide and Formoterol Fumarate.
Chapter 14 and 15, to describe Budesonide and Formoterol Fumarate sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Budesonide and Formoterol Fumarate Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 80/4.5 μg / inhalation
- 1.3.3 160/4.5 μg / inhalation
- 1.4 Market Analysis by Dosage Form
- 1.4.1 Overview: Global Budesonide and Formoterol Fumarate Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
- 1.4.2 Inhalation Powder
- 1.4.3 Inhalation Aerosol
- 1.5 Market Analysis by Production Technology
- 1.5.1 Overview: Global Budesonide and Formoterol Fumarate Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
- 1.5.2 Innovator
- 1.5.3 Generic
- 1.6 Market Analysis by Sales Channels
- 1.6.1 Overview: Global Budesonide and Formoterol Fumarate Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospitals
- 1.6.3 Retail
- 1.6.4 Online
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Budesonide and Formoterol Fumarate Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Asthma
- 1.7.3 Chronic Obstructive Pulmonary Disease
- 1.7.4 Airway Constriction Relief
- 1.7.5 Others
- 1.8 Global Budesonide and Formoterol Fumarate Market Size & Forecast
- 1.8.1 Global Budesonide and Formoterol Fumarate Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Budesonide and Formoterol Fumarate Sales Quantity (2021-2032)
- 1.8.3 Global Budesonide and Formoterol Fumarate Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 AstraZeneca
- 2.1.1 AstraZeneca Details
- 2.1.2 AstraZeneca Major Business
- 2.1.3 AstraZeneca Budesonide and Formoterol Fumarate Product and Services
- 2.1.4 AstraZeneca Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 AstraZeneca Recent Developments/Updates
- 2.2 Viatris
- 2.2.1 Viatris Details
- 2.2.2 Viatris Major Business
- 2.2.3 Viatris Budesonide and Formoterol Fumarate Product and Services
- 2.2.4 Viatris Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Viatris Recent Developments/Updates
- 2.3 Teva
- 2.3.1 Teva Details
- 2.3.2 Teva Major Business
- 2.3.3 Teva Budesonide and Formoterol Fumarate Product and Services
- 2.3.4 Teva Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Teva Recent Developments/Updates
- 2.4 Sandoz
- 2.4.1 Sandoz Details
- 2.4.2 Sandoz Major Business
- 2.4.3 Sandoz Budesonide and Formoterol Fumarate Product and Services
- 2.4.4 Sandoz Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sandoz Recent Developments/Updates
- 2.5 Chia Tai Tianqing Pharmaceutical
- 2.5.1 Chia Tai Tianqing Pharmaceutical Details
- 2.5.2 Chia Tai Tianqing Pharmaceutical Major Business
- 2.5.3 Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Product and Services
- 2.5.4 Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
- 2.6 Joincare Pharmaceutical Group Industry
- 2.6.1 Joincare Pharmaceutical Group Industry Details
- 2.6.2 Joincare Pharmaceutical Group Industry Major Business
- 2.6.3 Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Product and Services
- 2.6.4 Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Joincare Pharmaceutical Group Industry Recent Developments/Updates
- 2.7 Lunan Pharmaceutical Group
- 2.7.1 Lunan Pharmaceutical Group Details
- 2.7.2 Lunan Pharmaceutical Group Major Business
- 2.7.3 Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Product and Services
- 2.7.4 Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Lunan Pharmaceutical Group Recent Developments/Updates
3 Competitive Environment: Budesonide and Formoterol Fumarate by Manufacturer
- 3.1 Global Budesonide and Formoterol Fumarate Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Budesonide and Formoterol Fumarate Revenue by Manufacturer (2021-2026)
- 3.3 Global Budesonide and Formoterol Fumarate Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Budesonide and Formoterol Fumarate by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Budesonide and Formoterol Fumarate Manufacturer Market Share in 2025
- 3.4.3 Top 6 Budesonide and Formoterol Fumarate Manufacturer Market Share in 2025
- 3.5 Budesonide and Formoterol Fumarate Market: Overall Company Footprint Analysis
- 3.5.1 Budesonide and Formoterol Fumarate Market: Region Footprint
- 3.5.2 Budesonide and Formoterol Fumarate Market: Company Product Type Footprint
- 3.5.3 Budesonide and Formoterol Fumarate Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Budesonide and Formoterol Fumarate Market Size by Region
- 4.1.1 Global Budesonide and Formoterol Fumarate Sales Quantity by Region (2021-2032)
- 4.1.2 Global Budesonide and Formoterol Fumarate Consumption Value by Region (2021-2032)
- 4.1.3 Global Budesonide and Formoterol Fumarate Average Price by Region (2021-2032)
- 4.2 North America Budesonide and Formoterol Fumarate Consumption Value (2021-2032)
- 4.3 Europe Budesonide and Formoterol Fumarate Consumption Value (2021-2032)
- 4.4 Asia-Pacific Budesonide and Formoterol Fumarate Consumption Value (2021-2032)
- 4.5 South America Budesonide and Formoterol Fumarate Consumption Value (2021-2032)
- 4.6 Middle East & Africa Budesonide and Formoterol Fumarate Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Budesonide and Formoterol Fumarate Sales Quantity by Type (2021-2032)
- 5.2 Global Budesonide and Formoterol Fumarate Consumption Value by Type (2021-2032)
- 5.3 Global Budesonide and Formoterol Fumarate Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Budesonide and Formoterol Fumarate Sales Quantity by Application (2021-2032)
- 6.2 Global Budesonide and Formoterol Fumarate Consumption Value by Application (2021-2032)
- 6.3 Global Budesonide and Formoterol Fumarate Average Price by Application (2021-2032)
7 North America
- 7.1 North America Budesonide and Formoterol Fumarate Sales Quantity by Type (2021-2032)
- 7.2 North America Budesonide and Formoterol Fumarate Sales Quantity by Application (2021-2032)
- 7.3 North America Budesonide and Formoterol Fumarate Market Size by Country
- 7.3.1 North America Budesonide and Formoterol Fumarate Sales Quantity by Country (2021-2032)
- 7.3.2 North America Budesonide and Formoterol Fumarate Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Budesonide and Formoterol Fumarate Sales Quantity by Type (2021-2032)
- 8.2 Europe Budesonide and Formoterol Fumarate Sales Quantity by Application (2021-2032)
- 8.3 Europe Budesonide and Formoterol Fumarate Market Size by Country
- 8.3.1 Europe Budesonide and Formoterol Fumarate Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Budesonide and Formoterol Fumarate Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Budesonide and Formoterol Fumarate Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Budesonide and Formoterol Fumarate Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Budesonide and Formoterol Fumarate Market Size by Region
- 9.3.1 Asia-Pacific Budesonide and Formoterol Fumarate Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Budesonide and Formoterol Fumarate Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Budesonide and Formoterol Fumarate Sales Quantity by Type (2021-2032)
- 10.2 South America Budesonide and Formoterol Fumarate Sales Quantity by Application (2021-2032)
- 10.3 South America Budesonide and Formoterol Fumarate Market Size by Country
- 10.3.1 South America Budesonide and Formoterol Fumarate Sales Quantity by Country (2021-2032)
- 10.3.2 South America Budesonide and Formoterol Fumarate Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Budesonide and Formoterol Fumarate Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Budesonide and Formoterol Fumarate Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Budesonide and Formoterol Fumarate Market Size by Country
- 11.3.1 Middle East & Africa Budesonide and Formoterol Fumarate Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Budesonide and Formoterol Fumarate Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Budesonide and Formoterol Fumarate Market Drivers
- 12.2 Budesonide and Formoterol Fumarate Market Restraints
- 12.3 Budesonide and Formoterol Fumarate Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Budesonide and Formoterol Fumarate and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Budesonide and Formoterol Fumarate
- 13.3 Budesonide and Formoterol Fumarate Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Budesonide and Formoterol Fumarate Typical Distributors
- 14.3 Budesonide and Formoterol Fumarate Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Budesonide and Formoterol Fumarate. Industry analysis & Market Report on Budesonide and Formoterol Fumarate is a syndicated market report, published as Global Budesonide and Formoterol Fumarate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Budesonide and Formoterol Fumarate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
